Name: Annovis Bio, Inc. (ANVS) Balance Sheet
Creator: FinSpry

Annovis Bio Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Annovis Bio, Inc. (ANVS) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	10.55	5.75	28.38	45.69	8.07
Cash & Short-Term Investments	10.55	5.75	28.38	45.69	8.07
Accounts Receivable	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	3.37	0.04	0.10	0.07	0.04
Total Current Assets	13.93	10.21	36.02	46.00	8.12
Non-Current Assets
Property, Plant & Equipment (Net)	0.00	0.00	0.00	0.00	0.00
Other Non-Current Assets	0.00	0.00	0.00	0.00	0.00
Total Non-Current Assets	0.00	0.00	0.00	0.00	0.00
Total Assets	13.93	10.21	36.02	46.00	8.12
Current Liabilities
Accounts Payable	2.31	1.29	3.96	0.69	0.34
Accrued Liabilities	1.58	2.99	3.74	0.82	0.24
Other Current Liabilities	1.58	0.00	0.00	0.00	0.00
Total Current Liabilities	3.88	4.28	7.70	1.51	0.58
Non-Current Liabilities
Long-Term Debt	0.00	0.00	0.00	0.00	0.00
Other Non-Current Liabilities	0.74	13.68	0.00	0.00	0.00
Total Non-Current Liabilities	0.74	13.68	0.00	0.00	0.00
Total Liabilities	4.62	17.96	7.70	1.51	0.58
Stockholders' Equity
Common Stock	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-134.85	-110.26	-54.05	-28.73	-14.24
Additional Paid-in Capital	144.16	102.51	82.38	73.22	0.00
Shares Outstanding	14.14	10.52	8.16	8.10	0.00
Total Stockholders' Equity	9.31	-7.75	28.32	44.49	7.54
Total Liabilities & Equity	13.93	10.21	36.02	46.00	0.00